41244-51-3 Usage
Description
(+/-)-N,N-Bis-(2-hydroxy-ethyl)-alanin is a chemical compound that belongs to the class of amino alcohols. It is a derivative of alanine, an essential amino acid, and contains two hydroxyethyl groups attached to the nitrogen atom of the alanine molecule. (+/-)-N,N-Bis-(2-hydroxy-ethyl)-alanin has been studied for its potential pharmaceutical applications, particularly in the development of new drugs.
Uses
Used in Pharmaceutical Industry:
(+/-)-N,N-Bis-(2-hydroxy-ethyl)-alanin is used as a chiral building block for the synthesis of various pharmaceutical compounds. Its unique structure allows for the creation of enantiomerically pure molecules, which is crucial for the development of effective and safe drugs.
Used in Metal-Based Therapies:
(+/-)-N,N-Bis-(2-hydroxy-ethyl)-alanin is known for its ability to form stable complexes with metal ions. This property may have implications in metal-based therapies, where the compound could potentially be used to deliver metal ions to specific targets in the body, enhancing the therapeutic effects.
Used in Asymmetric Catalysis:
(+/-)-N,N-Bis-(2-hydroxy-ethyl)-alanin has been investigated for its potential as a chiral ligand in asymmetric catalysis. It has shown promising results in certain chemical reactions, which could lead to the development of more efficient and selective catalytic processes in the synthesis of enantiomerically pure compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 41244-51-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,2,4 and 4 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 41244-51:
(7*4)+(6*1)+(5*2)+(4*4)+(3*4)+(2*5)+(1*1)=83
83 % 10 = 3
So 41244-51-3 is a valid CAS Registry Number.
41244-51-3Relevant articles and documents
Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions
-
, (2008/06/13)
The invention concerns the discovery of the surprising and unexpected therapeutic effects of hydroxyl ions. The observed medicinal properties of these ions are both novel and broad in scope. The acute corrosive effects and toxicity of hydroxyl ions on living tissue has previously overwhelmed their therapeutic attributes. Unique hydroxyl ion modulating compounds have been discovered and are within the scope of the invention. When used appropriately as companions with hydroxyl ions, these modulating compounds obviate and attenuate the harmful effects of hydroxyl ions, unmasking and revealing their previously unknown and undemonstratable therapeutic properties. These hydroxyl ion modulating compounds do not significantly interfere with the surprising and unexpected therapeutic benefits of the hydroxyl ions. The novel hydroxyl ion modulating compounds are generally characterized as N,N-disubstituted-aminoacetate salts and substituted N,N-substituted-aminoacetate salts.
